Abstract
Background Assess the ability of APACHE II (acute physiology and chronic health evaluation II), SOFA (sequential organ failure assessment scores), Cardiac Surgery Score (CASUS) and SAVE (Survival after VA-ECMO) to predict outcomes in a cohort of patients undergoing Veno-Arterial ECMO (VA-ECMO).
Methods Observational retrospective study of all patients admitted to Cardiothoracic Intensive Care Unit (CTICU) for a minimum duration of 24 hours after undergoing VA-ECMO insertion between years 2015 to 2022. Scores for APACHE II, SOFA and CASUS were calculated at 24 after ICU admission. SAVE score was calculated from the last available patient details within 24 hours of ECMO insertion. Demographic, clinical, and laboratory data relevant for the study was retrieved from electronic patient records.
Results Pre-ECMO serum levels of lactates and creatinine were significantly associated with mortality. Lower ECMO flow rates at 4 hours and 12 hours after ECMO cannulation was significantly associated with survival to discharge. Development of arrythmias, acute kidney injury (AKI) and need of continuous renal replacement therapy (CRRT) while on ECMO were significantly associated with mortality. The APACHE-II, SOFA and CASUS, calculated at 24 hours of ICU admission were significantly higher amongst non-survivors. Following categorization of risk scores using ROC curve analysis, it was found that APACHE-II, SOFA and CASUS calculated at 24 hours of ICU admission after ECMO insertion demonstrated moderate predictive ability for mortality whereas SAVE score failed to predict mortality. APACHE-II >27 (AUC of 0.66) calculated at 24 hours of ICU admission after ECMO insertion, demonstrated the greatest predictive ability, for mortality. Multivariate logistic regression analysis of the four scores showed that APACHE-II > 27 and SOFA > 14 calculated at 24 hours of ICU admission after ECMO insertion, were independently significantly predictive of mortality.
Conclusions The APACHE-II, SOFA and CASUS, calculated at 24 hours of ICU admission were significantly higher amongst non-survivors as compared to survivors. APACHE-II demonstrated the best mortality predictive ability. APACHE-II scores of 27 or above, and SOFA of 14 or above at 24 hours of ICU admission after ECMO cannulation can predict mortality and will aid physicians in decision making.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors were not in receipt of any external funding for the purpose of the study. The study was funded by authors? parent institute.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee /IRB of HAMAD MEDICAL CORPORATION, PO Box 3050,Doha,Qatar gave ethical approval for this work. Informed consent from study subjects was waived as this was a research involving the collection or study of existing data, documents, records and the information is recorded by the investigator in such a manner that subjects cannot be identified, directly or through identifiers linked to the subjects.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The generated datasets from the current study are not publicly available but are available from the corresponding author on reasonable request through the regulations of the medical research center of the Institute.
List of abbreviations
- ACEF
- Age, Creatine, Ejection Fraction
- AKI
- Acute kidney injury
- AKIN
- Acute Kidney Injury Network
- AMI
- acute myocardial infarction
- APACHE II
- Acute Physiology and Chronic Health Evaluation II
- aPTT
- Activated partial thromboplastin time
- AUC
- Area under the curve
- CABG
- coronary artery bypass grafting
- CASUS
- Cardiac Surgery Score
- CI
- Confidence interval
- CPB
- Cardio-pulmonary bypass
- CRRT
- Continuous renal replacement therapy
- CS
- Cardiogenic shock
- CTICU
- Cardiothoracic Intensive Care Unit
- ECLS
- Extracorporeal life support
- ECMO
- Extra-corporeal Membrane oxygenation
- ECPR
- Extracorporeal cardio-pulmonary resuscitation
- ELSO
- Extra Corporeal Life Support Organization
- ENCOURAGE
- prEdictioN of Cardiogenic shock OUtcome foR AMI patients salvaGed by VA-ECMO
- IABP
- Intra-aortic balloon pump
- ICU
- Intensive Care Unit
- IQR
- inter-quartile range
- LR+
- likelihood ratio of a positive test
- LR-
- likelihood ratio of a negative test
- LOS ICU
- Duration of ICU stay
- LOS HOSP
- Duration of Hospital stay
- LOV
- Length of Ventilation
- MCS
- Mechanical Circulatory support
- NPV
- Negative predictive value
- POD
- Post-operative day
- POCT
- point-of-care test
- PPV
- positive predictive value
- REMEMBER
- pRedicting mortality in patients under-going veno-arterial Extracorporeal MEMBrane oxygenation after coronary artEry bypass gRafting
- ROC
- Receiver operating curve
- SAPS II
- Simplified Acute Physiology Score II
- SAVE
- Survival after VA-ECMO
- SD
- standard deviation
- SOFA
- Sequential Organ Failure Assessment
- VA-ECMO
- Veno-arterial extracorporeal membrane oxygenation
- VAV-ECMO
- Veno-arterio-venous extracorporeal membrane oxygenation
